Barry E. Greene, President at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 63,150 shares at $42.61 ($2.7M) on 2016-12-01, disclosed to the SEC on 2016-12-05.
Seasonal sale ($2.7M) by President — this insider has traded ALNY in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.61 | 14,349 | $611K | 22.5% |
| 2 | $42.61 | 14,349 | $611K | 22.5% |
| 3 | $43.28 | 16,976 | $735K | 27.1% |
| 4 | $43.28 | 16,976 | $735K | 27.1% |
| 5 | $44.07 | 500 | $22K | 0.8% |
| Total | $42.98 avg | 63,150 |
| $2.7M |
| 100% |
| Filing → |
| SAGE | BUY | 2021-06-17 | $496K | — | Filing → |
| ALNY | SELL | 2020-09-11 | $11.0M | — | Filing → |
| ALNY | SELL | 2020-07-09 | $7.1M | — | Filing → |